Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications

Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications
 
Summary
 

$3,500.00

Negative Pressure Wound Therapy Market to 2017 - Recent Approvals in Japan and Large Diabetes Patient Pool in Emerging Countries to Present Opportunities for Growth

Negative Pressure Wound Therapy Market to 2017 - Recent Approvals in Japan and Large Diabetes Patient Pool in Emerging Countries to Present Opportunities for Growth
 
Summary
 

$3,500.00

Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications

Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications

 

Summary

 

$3,500.00

Nausea – Pipeline Review, H1 2012

Nausea – Pipeline Review, H1 2012

 

Summary

 

$500.00

Orphan Diseases Therapeutics in CNS to 2017 - Novel Agents such as AMR101 and ACR16 to Provide Treatment Options and Boost the Huntington’s Disease Segment

Orphan Diseases Therapeutics in CNS to 2017 - Novel Agents such as AMR101 and ACR16 to Provide Treatment Options and Boost the Huntington’s Disease Segment

 

Summary

 

$3,500.00

Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment

Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment

 

Summary

 

$3,500.00

Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

 

Summary

 

$3,500.00

Chronic Kidney Disease (CKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Chronic Kidney Disease (CKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

 

Summary

 

$3,500.00

Antidepressants Market to 2018 - Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives

Therapeutic Market Research Reports Analysis and Trends

 

Sub-Categories

Pages

Shopping cart

0 Items $0.00
GET UPTO
25%
Special Discounts

User login